INS and type 2 diabetes mellitus: T2DM is defined by pathophysiological changes in pancreatic cells as well as increased peripheral (e.g., liver, kidney, skeletal muscle, and adipose) tissue reactive oxygen species (ROS) and inflammation, which can occur downstream of the insulin receptor (IR) and its signalling pathways, resulting in an inadequate response to insulin levels.